* Information available to verified or subscribed users. The first stage in this process is to Register - please
click here to Register. If you have already Registered, please click here to login.
the role of the p53/MDM2 pathway in radioresistance and cellular motility
Early phase clinical trials, the role of the p53/MDM2 pathway in radioresistance and cellular motility, the therapeutic exploitation of the unfolded protein response in H&N cancer, treatment response in HPV +ve oropharyngeal cancer intraoperative radiotherapy, core and swallowing outcomes in late phase clinical trials involving patients with OPSCC, function sparing surgical strategies for H&N cancer - especially transoral laser microsurgery